HOME >> BIOLOGY >> NEWS
Young children with epilepsy seizures could benefit from animal model of disease

BOSTON -- Researchers have developed an animal model of infantile spasms, improving the likelihood of finding new treatments for the thousands of young children who suffer from these catastrophic epilepsy seizures, according to research to be presented at the American Academy of Neurologys 59th Annual Meeting in Boston, April 28 May 5, 2007.

Infantile spasms are a specific type of epilepsy seizure seen in infancy and early childhood. The disorder involves a sudden bending forward and stiffening of the body, arms, and legs. The seizures typically last one to five seconds and occur in clusters, ranging from two to 100 spasms at a time. There are few available treatments.

In two studies, the authors report developing a mouse model of infantile spasms that produces effects closely resembling human infantile spasms. The mouse model also responded to current treatments, including adrenocorticotrophic hormone (ACTH), in a similar manner.

Infantile spasms can last for months to years in children. Having an animal model that resembles this long duration is likely to be useful for analyzing the evolution of this disease, and how it is best treated in different stages, said study author O. Carter Snead, III, MD, with the University of Torontos Hospital for Sick Children in Toronto, Ontario, Canada, and Fellow of the American Academy of Neurology.

Since children with this disorder often develop it without any apparent cause, such a mouse model will also improve the likelihood of finding new treatments, said study author Miguel Cortez, MD, with the University of Torontos Hospital for Sick Children.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
25-Apr-2007


Page: 1

Related biology news :

1. Norwegian council names ASU researcher Outstanding Young Investigator
2. Young meerkats learn the emotion before the message in threat calls
3. UCSB Assistant Professor Patrick Daugherty wins Young Investigator Award from ACS
4. UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
5. 2006 European Young Investigator Awards
6. UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research
7. IOF-Novartis Young Scholars Awards presented to seven researchers from six countries
8. Young researchers recognised for scientific achievements
9. 4th International Conference on Teenage and Young Adult Cancer Medicine
10. Rutgers Wise Young named to Esquires Best and Brightest of 2005
11. Young athletes ignore skin cancer risk

Post Your Comments:
(Date:3/23/2015)... 23, 2015   HOYOS Labs , a leading ... announced that the Company will demonstrate multiple biometrics-based technologies ... consumers at Connect:ID on March 23 through 25, 2015, ... will highlight the IEEE Biometric Open Protocol Standard; free ... enterprise access control system. BOPS was invented by HOYOS ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
(Date:3/17/2015)... SAN DIEGO , March 17, 2015 /PRNewswire/ ... and emotion analytics software, today announced general availability ... on-demand web service for the analysis of facial ... they experience advertising, media content, products and services. ... customer attention, engagement and sentiment - as derived ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
(Date:4/16/2015)... Grove, IL (PRWEB) April 16, 2015 ... the American Association for Cancer Research (AACR) annual ... the Pennsylvania Convention Center, starting Saturday, April 18, in ... AACR holds claim to title of the oldest and ... journals, provides fellowships and grants, and partners with survivors ...
(Date:4/16/2015)...  In recognition of World Hemophilia Day, Biogen  (NASDAQ: ... illuminate more than 15 prominent landmarks red throughout ... Zakim Bridge and Prudential Tower, Chicago,s ... Superdome and Denver,s Coors Field ... 17, and coincide with hemophilia community events in a dozen ...
(Date:4/16/2015)... , April 16, 2015 ... the Russian pharmaceutical investment and R&D group, ... collaboration for research, development and commercialization of ... with the intention to stimulate the ...      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     (Logo: ...
(Date:4/16/2015)... 2015 Avelas Biosciences, an in vivo ... announced today that it has initiated a Phase 1b ... women with primary, non-recurrent breast cancer undergoing surgery. In ... addition of Steven Chen , M.D., as vice ... dose escalation study will enroll up to 39 women ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
Cached News: